DanielChristophJulienMDMS

Pediatric Hematology & Oncology • Phoenix, AZ

Pediatric Hematology & Oncology Hospitalist

Join to view full profile

Dr. Julien is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Julien's full profile

Already have an account?

Office
1919 E Thomas Rd

Phoenix, AZ 85016
Phone+1 602-546-2923

Education & Training

Phoenix Children's HospitalFellowship, Pediatric Hematology/Oncology, 2016
Phoenix Children's HospitalResidency, Pediatrics, 2014
University of Washington School of MedicineClass of 2014

Certifications & Licensure

AZ State Medical License 2017 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

20 citations
Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer
Daniel C. Julien, Steven Behnke, Guankui Wang, Gordon K. Murdoch, Rodney A. Hill
Mabs. 2011-09-01
9 citations
Immune Modulation for Enzyme Replacement Therapy in A Female Patient With Hunter Syndrome.
Daniel C. Julien, Kara Woolgar, Laura Pollard, Holly K. Miller, Ankit K. Desai
Frontiers in Immunology. 2020-05-21
10 citations
In vitro proliferating cell models to study cytotoxicity of silica nanowires
Daniel C. Julien, Casey C. Richardson, Miles F. Beaux, David N. McIlroy, Rodney A. Hill
Nanomedicine. 2010-02-01

Journal Articles

Small interfering RNA to treat pancreatic cancer.
Julien DC, Giri A, Hill RA., Journal of Investigative Medicine., 1/2013
A comparative study of pluripotency markers in embryonic stem cells and induced pluripotent stem cells.
Julien DC, Verma K, Zambidis E., Journal of Investigative Medicine., 1/2012

Press Mentions

Teleperformance to Support Covid-19 Vaccinations for Its Employees WorldwideJanuary 19th, 2021
Teleperformance‘S Achievements in the Fight Against COVID-19April 6th, 2020
Réalisations De Teleperformance Dans La Lutte Contre COVID-19 :April 6th, 2020

Research History

Cupid Research Fellow: Johns Hopkins Hospital Baltimore, MDMember of the Zambidis laboratory- conducted experiments utilizing induced pluripotent stem cells.2011 - 2011
Research Fellow: University of IdahoResearch focus: The utilization of nanomaterials as intracellular drug delivery systems for the treatment of cancer.2006 - 2010